biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Before we go too far...

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Dec 09, 2022 2:15pm

166 Views

Post# 35162346

RE:RE:Before we go too far...

And it's also clear that Bioasis and its IR have been talking to some shareholders about me, revealing stuff that I never revealed to anybody.

That's interesting. Obviously it's no big deal for me to talk about it either.

It's all covered in my recent "Secrets" post.

Bioasis is discussing my relationship with the company with shareholders, and it's now been documented here.

jd

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario